Skip to content

Tuesday, December 3, 2024

Latest:

Researchers discovered compound produced by the body that regulates appetite
Permanent contraception procedures: vasectomy vs. tubal ligation
Dieting for the holidays? A registered dietitian explains how to stay healthy and on track
Managing diabetes to prevent complications: insights from Baylor Medicine experts
How to avoid arguments by setting boundaries with family

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

PARP inhibitor

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951